29 January 2018 - HAS has posted the agenda for the next scheduled TC meeting. ...
11 December 2017 - HAS has posted the agenda for the next scheduled TC meeting. ...
22 November 2017 - HAS has posted the agenda for the next scheduled TC meeting. ...
20 October 2017 - HAS has posted the agenda for the next scheduled TC meeting. ...
12 October 2016 - HAS has published the agenda for the next scheduled Transparency Commission meeting. ...
19 September 2016 - The Transparency Commission will consider the reimbursement of a number of new medicines and blood products. ...
15 July 2016 - The Transparency Commission will consider the reimbursement of new medicines and blood products. ...
30 June 2016 - The Transparency Commission will consider the reimbursement of new medicines and blood products. ...
1 June 2016 - The Transparency Commission will consider the (continued) reimbursement of dexketoprofen with tramadol hydrochloride (Skudexum), empagliflozin (Jardiance), plasma ...
22 May 2016 - The Transparency Commission will consider the (continued) reimbursement of voriconazole (Vfend), belatacept (Nulojix), bevacizumab (Avastin), bicalutamide (Casodex), ...
29 January 2016 - The Transparency Commission will consider the reimbursement of sufentanil (Zalviso), efmoroctocog alfa (Elocto) and asfotase alfa (Stensiq). ...
18 January 2016 - The Transparency Commission will consider the reimbursement of dronedarone hydrochloride (Multaq), palonosetron hydrochloride (AloxI), lanreotide acetate ...
4 October 2015 - The agenda for the 7 October 2015 TC meeting is now available. The Commission considered the following ...